In summary, we found that the expression of RASAL2 increased in PDAC as compared to normal pancreatic tissues, promoted tumor cell proliferation, migration and invasion, and high expression of RASAL2 predicted a poor prognosis in PDAC patients. This evidence concerns the gene RASAL2 and neoplasm.